Babraham Institute Enterprise Limited (BIE) is the wholly-owned trading arm of the Babraham Institute. The Babraham Institute undertakes innovative life-sciences research to discover the molecular mechanisms that underlie normal cellular processes and functions, with the aim of improving lifelong wellbeing and healthy ageing. It is based on the Babraham Research Campus near Cambridge, which is also home to early-stage biomedical companies.
The Babraham Institute aims to maximise the impact of its research through knowledge exchange and commercialisation, and its scientists work with other organisations to translate that research into action for social and economic benefit. BIE supports the delivery of the commercialisation of the Babraham Institute's science. As part of this role, it manages, develops and commercialises the Babraham Institute's intellectual property portfolio. It also facilitates collaborations between the Institute and industry, and arranges access to the Institute's expertise and scientific facilities and services.
Company Details
Babraham Institute Enterprise Ltd Questions
Babraham Institute Enterprise Ltd's website is http://www.babraham.ac.uk/industry
Babraham Institute Enterprise Ltd's LinkedIn profile is https://uk.linkedin.com/company/babraham-commercialisation-services-ltd
Babraham Institute Enterprise Ltd has
6 employees.
View email and phone details for 6
employees at Babraham Institute Enterprise Ltd.
Babraham Institute Enterprise Ltd's industry is
Biotechnology Research
Babraham Institute Enterprise Ltd's top competitors are
Cambridge Science Park,
Wellcome Sanger Institute,
One Nucleus,
Bit.bio,
Babraham Research Campus,
Autolus Therapeutics,
Cell And Gene Therapy Catapult,
Cancer Research Uk (Cruk),
Gsk,
Charm Therapeutics.
Babraham Institute Enterprise Ltd's categories are Biotechnology Research
Babraham Institute Enterprise Ltd's founding year is 2013
